Integrated Treatment for Enhancing Growth in Recovery During Adolescence

Launched by MASSACHUSETTS GENERAL HOSPITAL · Apr 29, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment approach designed to help teenagers and young adults aged 14 to 21 who are dealing with problems related to alcohol and drug use. The trial compares two different types of therapy to see which one helps participants engage more in recovery programs, stay abstinent from substances, and reduce negative consequences from their substance use. Participants will be recruited from clinical settings and the community in Boston, Massachusetts, and Farmington, Connecticut.

To be eligible for the study, participants should be between 14 and 21 years old, have been diagnosed with a substance use disorder, and have used substances in the last 90 days. They should also be able to understand English at a basic level and have a family member or guardian who can help with the study. Throughout the trial, participants will receive support through counseling and will be monitored for any changes in their recovery journey. This is a great opportunity for young people to receive help and support tailored to their needs while contributing to important research that may benefit others in the future.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • 1. 14-21 years old
• • 2. SUD based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)
• • 3. able to read and comprehend English at a 5th-grade level
• • 4. residence in Massachusetts or Connecticut
• • 5. any AOD use in the past 90 days (or in the 90 days prior to being in a controlled environment)
• • 6. meet patient placement criteria for level I (outpatient) treatment
• • 7. participant and a family member/guardian responsible for providing collateral information (for those \<18 years) agree to sign Institutional Review Board (IRB)-approved consent
• • 8. participant and family member responsible for providing collateral information who could be contacted in case the subject became lost to follow-up.
• Exclusion criteria:
• • 1. suicidal ideation with a plan, suicidal behavior, a plan to hurt oneself or others, or a history of self-injurious behavior occurring in past 30 days
• • 2. lifetime diagnosis of schizophrenia
• • 3. current health condition (i.e., medical, psychiatric) that compromises participant's ability to attend outpatient treatment
• • 4. demonstrate inability or unwillingness to identify a "locator" who could be contacted in case participant becomes lost to follow-up; or
• • 5. youth attending another SUD treatment program or receiving psychotherapy that could conflict with study treatments.